Search Results Page

Biocon remains in the red

about 9 years ago

Biocon has tanked big time today over 6% to Rs.343.50 the moment it opened for trade but has since then recovered to Rs.357 levels though remains in the red. Its 52-week low

Biocon hits new high, again

about 8 years ago

The stock price of Biocon reacted through this week to the news which it announced on Saturday, hitting new highs since Monday.

Biocon slumps after poor Q3

about 9 years ago

Not surprisingly, Biocon is the top loser on the BSE since the opening bell. The stock lost 5.5% to slip down to Rs.600.32. Its 52-week high and low stands at Rs.657.75 and Rs.294.71 respectively.

Biocon hits a lifetime high, again

about 10 years ago

On 10th Jan, Biocon had hit a lifetime high at Rs.1026 and today, once again it is another new high at Rs.1052.05, with volumes jumping up almost two times. The reason for this euphoria is on account of the news that US FDA has accepted Mylan’s biologics licence application for its bio ...

Biocon spurts to good health

about 8 years ago

Biocon is shining bright on this record breaking day of stock rise. The stock is currently the second top gainer on the BSE, up 7% at Rs.598.

Biocon in the positive

about 7 years ago

Biocon began a really shinning bright star, opening the day almost 5% higher at Rs.299.70, after which it slipped to Rs.289 levels.

Biocon in the limelight

about 7 years ago

Biocon is in the limelight today, good limelight too. The stock opened in the green, up over 2% at Rs.270 and went on to an intra day high at Rs.277.60, up 5%.

Biocon close to its life-time high

about 11 years ago

Biocon has been consistently hitting a new high for the past couple of days. Today too, it hit a new high at Rs.734.70, up over 4.5%. Its all-time high is at Rs.739.40, hit in April 2004 and the stock was inches close to that today. The reason for this euphoria on the counters of Biocon is t ...

Biocon slips over 3%

about 7 years ago

Biocon opened 3% lower today morning at Rs.227.90 and went down further to an intraday low at Rs.226.40. It has recovered a bit but remains very much in the red.

Biocon hits a new high

about 9 years ago

Biocon is the news maker today morning. The top gainer on the BSE, it first breached the UC at Rs.491.20, going on to hit a new high at Rs.510. On Friday, it had closed at Rs. 446.55.

Biocon up 3% on strong Q1

about 11 years ago

Shares of Asia’s premier biopharmaceutical company Biocon Limited are up close to 3% at Rs. 471.60, a piece, with healthy volumes on both the exchanges. While being debt-free, company’s market cap exceeds Rs. 9,400 crore currently. The company, led by Dr. Kiran Mazumdar ...

Biocon in the spotlight

about 9 years ago

Biocon is in the spotlight today. The stock price has risen over 2.5% to Rs.628.50 and its 52-week high stands at Rs.657.75. The stock attracts a 10% circuit and the UC is at Rs.674.45.

Biocon gives bonus surprise!

about 10 years ago

Biocon most surely sprung a surprise on everyone! The top gainer on the BSE currently, hitting a new high at Rs.1168, with some 5 times surge in volumes since opening bell, the stock is rocking today!

Biocon hits a new high

about 8 years ago

Biocon has been having a volatile run on the bourses today. It first hit a new high today at Rs.695 and it is now in the red, down 3% at Rs.634.

Biocon holds its steed in the green

about 7 years ago

Biocon has been gaining for the last 3 days and has risen 3.38% in the period. The stock opened higher by 1% at Rs.225 and rose further to Rs.225.85, its intraday high.

Biocon rises and slips

about 7 years ago

Biocon is a tad wild today. It opened in the positive at Rs.265.80 and even rose to an intraday high at Rs.272.55, rising almost 3,5%. But at that level, profit booking seems to have kicked in and the stock price tumbled down to Rs.256.95

Biocon remains in the red

about 9 years ago

Biocon continues to fall today too. Figuring amongst the top five losers on the BSE, slipping over 3% to Rs.318.85. It has recovered since then but remains in the red.

Biocon slips on FDA 'observation'

about 8 years ago

Obviously, any FDA inspection, that too with observations never goes down well with the market. The stock price fell almost 3% to Rs.608.50

Biocon slips 7%

about 7 years ago

Th stock had good news to share but the overall bearish mood on the markets, kept the stock in the red.

Biocon has good news

about 7 years ago

The stock opened higher at Rs.280 and even went on to an intraday high at Rs.285.40. It is currently off the days high is at Rs.275 levels.

Biocon slips over 4%

about 7 years ago

The stock which had closed yesterday at Rs.335.30, opened lower today at Rs.325.05 and went down to an intraday low at Rs.320.90

Biocon rises and falls

about 6 years ago

The market is not giving this news too much weight. The stock, which had closed yesterday at Rs.358.60, opened flat

Biocon hits a new low

about 4 years ago

The stock which had closed yesterday at Rs.316.20, opened lower at Rs.313 and went down to hit a new 52-week low at Rs.308.25.

Biocon at new high

about 6 years ago

The stock which had closed yesterday at Rs.414.30, opened at a new 52-week high at Rs.455, just 10 paise short of hitting its 10% UC

Biocon surges 3%

about 6 years ago

The stock price rose almost 3% to Rs.467.70 with an over 1-time surge in volumes. Its 52-week high is at Rs.487.70.

Biocon down on "observations"

about 9 years ago

The market has reacted negatively to this news; it went down over 5% to Rs.630.30 and remains in the red now at Rs.635 levels.

Biocon jumps back into reckoning

about 9 years ago

The stock is today amongst the top five gainers on the BSE; the price rose 6.5% to Rs.419.75, very close to its 52-week high of Rs.424.15.

Biocon jumps up on good Q4

about 12 years ago

Biocon posted a strong performance for Q4FY15 despite the exceptional income of Rs.105 crore via sale of shares in Syngene, its R&D arm. Consolidated net profit showed a jump of a whopping 122% at Rs.201 crore. And PBT before exceptional income rose 32% at Rs.143 crore. Overall it has be ...

Biocon spurts up

about 1 year ago

The stock price has not reacted much though its making news with the price pricing little over 1% to Rs.381.80 with volumes also muted.

Biocon in the news

about 2 years ago

From its close of Rs.321.25, the stock opened slightly higher at Rs.326 and rose to an intraday high at Rs.338.60, up over 5.5%. Its 52-week high is at Rs.395.65.

Biocon slips after good numbers

about 13 years ago

Biocon is currently the top loser on the BSE, down almost 4% at Rs.462, with an intra day low at Rs.455. the stock had hit a new 52-week high yesterday at Rs.497.40 in anticipation of good earnings for Q3Fy14. The stock has slipped, mainly on profit booking though Q3Fy14 numbers came in much ...

Biocon in the green

about 13 years ago

Biocon is doing pretty well today, with the stock opening higher at Rs.444, going on to hit an intra day high at Rs.457.50 and currently hovers around the same levels. The stock is seeing activity today on the back of its announcement yesterday – the company’s subsidiary, Syngene ...

Biocon shines 'silver'

about 12 years ago

Biocon is a big star today on Dalal Street. The stock opened higher by around Rs.11 at Rs.510.35 and went on to an intra day high at Rs.514.90 and currently trades at Rs.512 levels. The stock is up after the company stated that Silver Leaf Oak (Mauritius) is picking up a 10% ...

Biocon down in red

about 5 years ago

The stock opened slightly higher at Rs.397 from its previous close of Rs.394.15 but once the announcement came, it slipped down to an intraday low at Rs.360, down over 8.5%

Biocon jumps on Syngene DRHP

about 12 years ago

Biocon is seeing some activity on its counter today. The stock, which has been lying low for some time now, is currently up 1.5% at Rs.463, with an intra day high at Rs.470.45. The company has filed a Draft red Herring Prospectus (DRHP) today morning for its wholly owned subsidiary, Syngene, ...

Biocon in limelight

about 5 years ago

The stock which had closed yesterday at Rs.376.90, the stock opened higher at Rs.392 and even went up to Rs.398.60.

Biocon hits a new 52-week high

about 11 years ago

Biocon hit a new 52-week high today at Rs.512 and the stock is up over 5.5% up. Volumes have jumped up to almost 2.5 lakh shares compared to two-week average of 41,000 shares. The company announced that it has introduced an advanced novel therapy CIMIVIR-L for the treatment of Hepatitis C in ...

Biocon slips and falls

about 9 years ago

The news was not very good from Biocon. The company’s three products at its Bengaluru facility failed to comply with Good Manufacturing Practices (GMP) as per France’s health regulator ANSM.

Biocon hits a life-time high

about 9 years ago

Biocon, which was down and beaten up past couple of days, was back in the reckoning today. From top loser two days ago, it was the top gainer since morning, going on to hit a new life-time high today at Rs.404.40 and is currently quoted at Rs.400 levels, up almost 9.5%.

Biocon posts super numbers

about 7 years ago

The markets have reacted positively but not exactly ecstatically, opening 5% higher at Rs.250.50 and hitting an intraday high at Rs.252, up 5.6%.

Biocon in the limelight today

about 11 years ago

Biocon is in the limelight today. From yesterday’s close of Rs.463.10, the stock zoomed to an intra day high at Rs.473.95 and it is now at Rs.464 levels, up 4.5%. The company announced today morning that it has got approval from the European Union (EU) for its first generic formulation ...

Biocon leads losers on BSE

about 12 years ago

Biocon is currently the top loser on the BSE, down almost 2.5% at Rs.467 and this is some bit of recovery from the low-point of the day at Rs.465. The stock is reacting to the flat set of numbers for Q2FY15. The company’s consolidated net profit came in flat (YoY) at Rs.102 crore as ag ...

Biocon hits a life time new high

about 10 years ago

The market is most obviously trilled to bits with the performance of Biocon. The company for Q1FY17 posted a 34% (YoY) jump in consolidated net profit at Rs.167 crore on a 21% jump in total revenue at Rs.982 crore. This performance was driven mainly by a strong uptick in two of its segments & ...

Biocon oscillates

about 7 years ago

The market does not know whether to be happy or sad about these numbers – the stock opened lower at Rs.289 and went on to an intraday high at Rs.296

Biocon hits a new life time high

about 10 years ago

Biocon hit a record high today at Rs.909.90, with some 2.5 times rise in volumes. The company announced yesterday after closing bell that Maylan’s application to market the biosimilar for treating certain breast and gastric cancers, Tarstuzumab has been accepted by the European Medicin ...

Biocon spurts up

about 2 years ago

The stock is among the top five gainers on the BSE since the opening bell; from its close of Rs.360,.65, it opened for trade at Rs.370.50 and rose to an intraday high at Rs.376.95, up 4.5%.

Biocon tanks on Form 483

about 9 years ago

The stock has tanked after the US FDA issued 10 observations pointing at aseptic practices after an inspection at the drugmaker's plant in Bengaluru.

Biocon in the red

about 6 years ago

The stock price has been in the red ever since Thursday and today too, it opened lower and went down 3.5% to Rs.401; it has recovered a bit

Biocon falls over 9.5%

about 6 years ago

The market gave the performance a thumbs down, with the stock price slipping over 9.5% to Rs.399.45, not to far from its 10% LC of the day

Biocon tanks on disappointing Q3

about 12 years ago

Biocon fell today morning after it declared its Q3FY15 performance. From yesterday’s close of Rs.426.15, it opened lower at Rs.421.50 and went down to the days low at Rs.411, a decline of 3.5%. The company posted a 13% (YoY) dip in net profit for the quarter at Rs.91 crore though reven ...

Pharma companies get "Trump"ed!

about 10 years ago

Dr.Reddy’s and Sun Pharma are amongst the top losers. The pharma index, which is known as the BSE Healthcare Index is down 1.3% and almost all the drug making companies, except for Biocon and Gufic are in the red. Blame it on Trump! After automobile and IT, the US President-elect has s ...

WHEN US FDA MEETS INDIAN PHARMA COMPANIES...

about 9 years ago

This is the thought which comes to mind when we read this news today about Biocon also being pulled by the ‘villain’ of Indian pharma companies – the U.S. Food and Drug Administration (U.S. FDA). The stock was down today as its Bengaluru unit has received ten observations on Form 483 by the FDA. This ranges right from nonconformity to procedures and lack of trained and skilled employees

Biocon's palor turns pale

about 9 years ago

Biocon is looking very pale and sickly today on the bourses. The stock dropped today almost 3.5% at Rs.553.15

ARE THE INDIAN MARKETS TOO EXPENSIVE?

about 10 years ago

relative recently asked the usual question which we all working in the field of stock market often get asked, "So market kaisa lagta hai? What to buy?" Once you start answering the questions, it's like a never ending tirade. And after you have given satisfactory answers and named a few stocks (all from our Stock Recommendation section), you think its over?

Anthem Biosciences

about 1 year ago

A ‘Blockbuster’
Subscription Start Date :14 Jul 2025 End Date :16 Jul 2025
Issue Size : Rs. 3,395 cr, Issue Type : OFS
Price Band : Rs.540 to Rs. 570
--------------------------------------------------
Overall Subscription : 63.86x
QIB : 182.65x,HNI :42.36x,Retail :5.64x,Other :6.6x
Listing Date : 21 Jul 2025, , Listing Price : 723

Syngene

about 11 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

MARKETS SAYING, “DON’T WORRY, BE HAPPY!”

about 10 years ago

The markets are most certainly in a jubilant mood. NSE and the BSE are at all-time highs. Yesterday, the BSE Sensex closing over 30,000 was a huge thing. The Indian rupee too hit a 20-month high at Rs.63.93, breaching the Rs.64-mark. The reasons are not very far to find.

WHAT ARE THE "FII STOCKS?"

about 10 years ago

It is always very fascinating to know where exactly or what which are the stocks in which the Foreign Institutional Investors (FIIs) are investing. No doubt, FIIs are the game changers and what they do matters to most on Dalal Street as the belief is that stocks which they buy will soar. We perceive FIIs to be something akin to a cushion - they give comfort and protect from the bumps. Before we question whether it is right to have so much faith in FIIs,

Munjal Auto

about 10 years ago

Munjal Auto Industries surged over 10% in the morning trades to Rs.110 just Rs.8 short of its 52-week high of Rs.117.80.

Anthem Bio makes great debut

about 1 year ago

The stock has made a fantastic debut; as against the IPO price of Rs.570, the stock was listed on the BSE at Rs.723.10 and rose to an intraday high at Rs.746.70 and is currently trading